FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/090098 [Registered on: 03/07/2025] Trial Registered Prospectively
Last Modified On: 19/06/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   Effect of Ayurvedic line of Management in adenoid enlargement in children. 
Scientific Title of Study   Effectiveness of selected Ayurveda management protocol in adenoid hypertrophy among children of age group 5 to 10 years. 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Musafar Ahammed 
Designation  PG Scholar Department of Shalakyatantra  
Affiliation  Government Ayurveda Medical College thiruvananthapuram kerala  
Address  Department of Shalakyatantra, Government Ayurveda college thiruvananthapuram Kerala. 695001.

Thiruvananthapuram
KERALA
695001
India 
Phone  9496952573  
Fax    
Email  musafarmarayi2016@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Musafar Ahammed 
Designation  PG Scholar Department of Shalakyatantra  
Affiliation  Government Ayurveda Medical College thiruvananthapuram kerala  
Address  Department of Shalakyatantra, Government Ayurveda college thiruvananthapuram Kerala. 695001.

Thiruvananthapuram
KERALA
695001
India 
Phone  9496952573  
Fax    
Email  musafarmarayi2016@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Kusumam Joseph  
Designation  Professor, Department of Shalakyatantra  
Affiliation  Government Ayurveda Medical College Thiruvananthapuram  
Address  Department of Shalakyatantra, Government Ayurveda college thiruvananthapuram Kerala. 695001.

Thiruvananthapuram
KERALA
695001
India 
Phone  9446187163  
Fax    
Email  kusumamjoseph123@gmail.com  
 
Source of Monetary or Material Support  
Government Ayurveda Medical College and Hospital Thiruvananthapuram. 695001 Kerala, India. 
 
Primary Sponsor  
Name  Dr. Musafar Ahammed  
Address  PG Scholar. Department of Shalakyatantra, Government Ayurveda college thiruvananthapuram Kerala. 695001. 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Musafar Ahammed   Government Ayurveda Medical Hospital Thiruvananthapuram   Department of Shalakyatantra, Government Ayurveda college Hospital thiruvananthapuram Kerala. 695001.
Thiruvananthapuram
KERALA 
9496952573

musafarmarayi2016@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICAL COMMITTEE (IEC)Government Ayurveda College, Thiruvananthapuram Kerala India   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:J352||Hypertrophy of adenoids. Ayurveda Condition: NASAROGAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Varanadi Kashaya , Reference: Ashtang Hridaya sutrasthana 15/21,22, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 25(ml), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 1 Months, anupAna/sahapAna: No, Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: Kanchanara guggulu tablet., Reference: Bhaishajya Ratnavali 44/64,69, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 1(g), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 1 Months, anupAna/sahapAna: No, Additional Information: -
3Intervention ArmDrugClassical(1) Medicine Name: Vilwadi tab , Reference: Ashtang Hridaya Uttarasthana 36/84,85, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 0.4(g), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 1 Months, anupAna/sahapAna: No, Additional Information: -
4Intervention ArmDrugClassical(1) Medicine Name: Saptamushtee yusha , Reference: Sharangdhara Samhita , Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 35(ml), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 1 Months, anupAna/sahapAna: No, Additional Information: -
5Intervention ArmProcedure-gaNDUShaH, गण्डूषः (Procedure Reference: Ashtanga Hridaya , Procedure details: Gandusha is a procedure holding any medicated liquid in mouth to its full capacity for a specific time without any movements inside the mouth. It can be done with Sneha dravyas, kashayas, ushnodaka, madhu, mamsarasa, madya, etc, according to dosha.)
 
Inclusion Criteria  
Age From  5.00 Year(s)
Age To  10.00 Year(s)
Gender  Both 
Details  Diagnosed cases of adenoid hypertrophy with breathing difficulty.
Patients between age group 5 years to 10 years, irrespective of gender, religion, and socio-economic status.  
 
ExclusionCriteria 
Details  Diagnosed cases of systemic disorders like renal and cardiac diseases
Diagnosed cases malignancy, TB, anemia and bleeding disorders.
Use of corticosteroids in all forms within 3 months of enrolment
Participants with Infectious adenoid hypertrophy.
Malnourished and underweight children.
Children with developmental delay 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To assess the effect of Varanadi Kashaya, Kanchanara guggulu tablet, Vilwadi tablet
and Trikatukadi gandusha followed by Saptamushtika yusha pana and pathyahara and
vihara in reducing the symptoms in participants of age group of 5-10 years irrespective
of gender diagnosed with adenoid hypertrophy. 
0th,30th,60th day 
 
Secondary Outcome  
Outcome  TimePoints 
To critically study adenoid hypertrophy in an Ayurvedic perspective.  0th,15th,30th, 60th day 
 
Target Sample Size   Total Sample Size="23"
Sample Size from India="23" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   04/08/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Adenoid hypertrophy is a condition characterized by obstruction of airway in the
nasopharyngeal region by the enlarged adenoids. Adenoids gets
hypertrophied with/without acute or chronic infection of the adenoid, obstructing the posterior nasal
opening and respiratory, nasal and aural symptoms are shown. Even though the hypertrophy gets
atrophied during puberty, it can create serious difficulties to the individual in the form of upper airway
obstruction associated with, nasal block, mouth breathing, obstructive sleep apnea, hypopnea, and
upper airway resistance syndrome (UARS) etc. At present Adenoidectomy is the only definite
management available for Adenoid hypertrophy, which can cause aftereffects like recurrent respiratory
infections and allergic reactions. Chances of regrowth is also up to 26% and recurrence of some
symptoms are also reported in many cases. No conservative managements are available at present. So,
an alternate management protocol is a necessity.The selected treatment protocol includes Varanadi
Kashaya, Kanchanara guggulu tablet, Vilwadi tablet, Trikatukadi gandusham for one month followed
by 1 month of pathyakala with Saptamushtika yusha panam which has kaphahara properties. 23
patients diagnosed with non-infectious adenoid hypertrophy of age group 5-10 years selected on the
basis of inclusion criteria attending OPD and IPD of Shalakyatantra, Govt. Ayurveda College,
Thiruvananthapuram will be subjected to the selected treatment protocol for 30 days followed by 1
month of pathya. Clinical evaluation will be done prior to the commencement of intervention, 15th day,
30th day and 60th day. Results will be statistically analyzed after the study by Kruskal-wallis test.
 
Close